HI
ABMD

HBK Investments’s Abiomed Inc ABMD Stock Holding History

HBK Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,217
Closed -$351K – 706
2020
Q2 		$294K Buy
+1,217
New +$244K ﹤0.01% 500
2020
Q1 		– Sell
-3,968
Closed -$677K – 565
2019
Q4 		$677K Buy
+3,968
New +$736K 0.01% 542
2016
Q4 		– Sell
-6,808
Closed -$875K – 925
2016
Q3 		$875K Buy
+6,808
New +$815K 0.01% 538
2015
Q4 		– Sell
-6,000
Closed -$557K – 1160
2015
Q3 		$557K Buy
+6,000
New +$529K 0.01% 725
2015
Q2 		– Sell
-4,100
Closed -$293K – 1143
2015
Q1 		$293K Buy
+4,100
New +$223K ﹤0.01% 864

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HBK Investments's ABMD Position: Q3 2020 in Review

HBK Investments sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 1,217 shares — an estimated $351K sold.

HBK Investments first reported a position in ABMD in Q1 2015 and held it in 5 quarters. The position peaked at $875K in Q3 2016. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • HBK Investments reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • HBK Investments sold 1,217 Abiomed Inc shares in Q3 2020, an estimated $351K.
  • HBK Investments first reported a position in Abiomed Inc in Q1 2015 and held it in 5 quarters.
  • HBK Investments's Abiomed Inc position peaked at $875K in Q3 2016.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on HBK Investments's 13F filing for Q3 2020, filed 16 Nov 2020.